mRNA technology a ‘Game Changer’ for Asia-Pacific vaccine manufacturers: Merck study

According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a “ga...

June 1, 2023 | Thursday | News
SK bioscience receives marketing authorisation of COVID-19 vaccine in UK

SK bioscience, based in South Korea, has announced the UK’s Medicines and Healthcare products Regulatory Agency (M...

May 31, 2023 | Wednesday | News
Devising a viable global strategy to combat Cholera

For reasons not yet fully understood, beginning in 2022 the world experienced an unprecedented surge in cholera outbreak...

May 31, 2023 | Wednesday | Opinion
Korea's International Vaccine Institute establishes Joint Research Institution in China

South Korea-based International Vaccine Institute (IVI) has sigend a Memorandum of Understanding (MoU) with Nankai ...

May 23, 2023 | Tuesday | News
China approves two COVID-19 vaccine trials against most recent circulating XBB variants

Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (S...

May 22, 2023 | Monday | News
World’s first and only oral cholera vaccine in LDPE unidose pack launches in India

TechInvention Lifecare in India, has partnered with Eubiologics Co. in  South Korea,  to  launch Euv...

May 12, 2023 | Friday | News
International partnership supports vaccine research to prevent future outbreaks

Jean-Yves Duclos, Minister of Health, and Harjit S. Sajjan, Minister of International Development and Minister responsib...

May 8, 2023 | Monday | News
Korea begins clinical development of new low-cost oral cholera vaccine in capsule form

The International Vaccine Institute (IVI), based in South Korea, has begun clinical development of DuoChol, a new low-co...

May 1, 2023 | Monday | News
US FDA approves Pfizer’s 20-valent Pneumococcal Conjugate Vaccine for children

American pharmaceutical firm Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has approved PREVN...

April 28, 2023 | Friday | News
Survey: One-third of COVID-19 vulnerable groups avoid booster shots

The results from a new YouGov survey called, ‘What’s Next for COVID-19 in Singapore?’, commissioned by...

April 25, 2023 | Tuesday | Company results
Singapore unveils new approach to aid pneumococcal vaccine development

Many disease-causing bacteria like Streptococcus pneumoniae (S. pneumoniae) are encased in a sugar layer called the caps...

April 20, 2023 | Thursday | News
BioMinhai and Biotis to promote development of vaccine industry in Indonesia

Beijing Minhai Biotechnology Co., (BioMinhai), a wholly-owned subsidiary of China-based Shenzhen Kangtai Biological Prod...

April 8, 2023 | Saturday | News
Sanofi opens state-of-the-art facility in US for pandemic flu vaccines production

Sanofi and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic ...

April 6, 2023 | Thursday | News
Korean firm DxVx completes Phase 1a clinical trial of novel cancer vaccine

DXVX has announced that its affiliated company Oxford Vacmedix (OVM) has completed Phase 1a trial of cancer vaccine and ...

April 3, 2023 | Monday | News
Australian biotech behemoth CSL unveils new vaccine R&D facility in US

Australian biotech firm CSL recently celebrated the official opening of the company's new state-of-the-art research and ...

March 28, 2023 | Tuesday | News
New funding by NZ to boost RNA research into vaccines & healthcare

Victoria University of Wellington and University of Auckland, in New Zealand (NZ) have been named as co-hosts of a ...

March 27, 2023 | Monday | News
Singapore gives nod to Pfizer’s Pneumococcal 20-valent conjugate vaccine for adults

American pharmaceutical firm Pfizer has announced that the Singapore Health Sciences Authority (HSA) has approved its 20...

March 22, 2023 | Wednesday | News
China's first personalised neoantigen-targeted cancer vaccine gets clinical trial approval

Likang Life Sciences has received National Medical Products Administration (NMPA) approval for the clinical trial of its...

March 17, 2023 | Friday | News